<DOC>
	<DOCNO>NCT00321906</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness two different anti-rejection drug regimen .</brief_summary>
	<brief_title>Comparison Sirolimus Azathioprine Lung Transplantation</brief_title>
	<detailed_description>This multicenter prospective , randomize control clinical trial compare open label use sirolimus azathioprine tacrolimus-based immunosuppression regimen . Eligible patient identify 90-day screening period immediately transplantation randomize via computer-generated scheme . Patient randomization stratify accord center rejection status first 90 day transplantation . All patient receive IL-2 receptor antagonist induction therapy , tacrolimus , azathioprine , corticosteroid 90 day transplantation . At 90 day transplantation , patient randomize 1:1 ratio either continue azathioprine change azathioprine sirolimus . The dosing level immunosuppressive medication standardize patient include study . Tacrolimus dose 0.04 mg/kg twice daily target trough level 5 15 ng/ml , azathioprine administer 2 mg/kg daily dose adjustment leukopenia , sirolimus initially dosed 2 mg/day target trough level 5 15 ng/ml , prednisone taper 10 mg/day 3 month transplantation . All patient receive induction therapy either daclizumab basiliximab per product package insert . In addition , prophylactic antimicrobial standardize among participate site . All patient either donor and/or recipient cytomegalovirus ( CMV ) -positive serostatus receive either intravenous ganciclovir oral valganciclovir total 90 day . Lung transplant recipient negative donor recipient CMV serostatus receive valacyclovir 90 day . Antifungal prophylaxis determine site . Pneumocystis jiroveci prophylaxis continue throughout study . Lipid-lowering medication recommend accord National Cholesterol Education Program guideline .</detailed_description>
	<mesh_term>Delayed Graft Function</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Lung transplant recipient age 18 65 year age . Females capable become pregnant must negative pregnancy test prior consent . ( Females childbearing potential must use medically acceptable method birth control duration study . ) All patient must able give write informed consent . White blood cell count ( WBC ) &lt; 4.0/mm3 Platelet count &lt; 100,000/mm3 Severe hypercholesterolemia ( &gt; 350 mg/dl ) hypertriglyceridemia ( &gt; 500 mg/dl ) Uncontrolled systemic infection time consent . Previous organ transplant Treatment drug within last 30 day receive regulatory approval time study entry duration study ( 3 year ) . Use maintenance immunosuppression daclizumab , tacrolimus , azathioprine , prednisone prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Rejection lung transplant</keyword>
</DOC>